The 2025 AABB Annual Meeting in San Diego highlighted significant advances across transfusion medicine, biotherapies and cord blood banking. This roundup features key sessions that explored emerging technologies, evolving donor trends and policies, clinical practice updates and technological advancements and innovations shaping the field.
Opportunities And Challenges In The Field Of Cord Blood And Birthing Tissues
Non-Medically Indicated Directed Blood Donation Requests Increasing
Brazilian Data Confirm IDA Not Associated with Increased HIV Risk
Examining the Future of Volunteer Blood Donation
No Change in HIV Prevalence In Blood Collections Following Implementation Of IDA
Cryopreserved Platelets Noninferior to RT Platelets in Cardiopulmonary Bypass
Assessing Clinical Outcomes Following Transfusion of Crossmatch-Incompatible RBCs
More Aggressive Measures May Be Needed to Further Reduce Wastage Of Blood Products
Bloodless Cardiac Surgery May Be Feasible Option, Following Appropriate Perioperative Protocols
The Impact of Reconstituted Whole Blood Products
Advancing Patient Care Through Out-Of-Hospital Transfusions
Should Transfusion Services Accept RBC Units Containing Unexpected Donor Alloantibodies?
In-House RBC Antigen Typing May Offer Cost Savings And Faster Availability
Spray-Dried Plasma May Offer Viable Alternative
PREVIOUS STORY
Tomas Ganz, 2025 Landsteiner-Alter Award Recipient, Reflects on His Scientific BreakthroughsBACK TO ISSUE
November/December 2025
Transfusion is AABB’s scholarly, peer-reviewed monthly journal, publishing the latest on technological advances, clinical research and controversial issues related to transfusion medicine, blood banking, biotherapies and tissue transplantation. Access of Transfusion is free to all AABB members.
Learn More About Transfusion Journal
Keep abreast of what's happening in the field of biotherapies with CellSource - AABB's monthly update on the latest biotherapies news.
To submit news about the blood and biotherapies field to AABB, please email news@aabb.org.
President
Meghan Delaney, DO, MPH
Chief Executive Officer
Debra Ben Avram, FASAE, CAE
Chief Communications and Engagement Officer
Julia Zimmerman
Director of Marketing and Communications
Jay Lewis, MPH
Managing Editor
Kendra Y. Mims, MFA
Senior Communications Manager
Drew Case
AABB News
(ISSN 1523939X) is published monthly, except for the combined November/December issue for the members of AABB; 4550 Montgomery Avenue; Suite 700 North Tower; Bethesda, MD 20814.
AABB is an international, not-for-profit association representing individuals and institutions involved in transfusion medicine, cellular therapies and patient blood management. The association is committed to improving health by developing and delivering standards, accreditation and educational programs that focus on optimizing patient and donor care and safety.
+1.301.907.6977
Email: news@aabb.org
Website: www.aabb.org
Copyright 2025 by AABB.
Views and opinions expressed in AABB News are not necessarily endorsed by AABB unless expressly stated.
Notice to Copiers: Reproduction in whole or part is strictly prohibited unless written permission has been granted by the publisher. AABB members need not obtain prior permission if proper credit is given.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
